BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 7254280)

  • 1. Biologic differences between neuroblastoma stages IV-S and IV. Measurement of serum ferritin and E-rosette inhibition in 30 children.
    Hann HW; Evans AE; Cohen IJ; Leitmeyer JE
    N Engl J Med; 1981 Aug; 305(8):425-9. PubMed ID: 7254280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic importance of serum ferritin in patients with Stages III and IV neuroblastoma: the Childrens Cancer Study Group experience.
    Hann HW; Evans AE; Siegel SE; Wong KY; Sather H; Dalton A; Hammond D; Seeger RC
    Cancer Res; 1985 Jun; 45(6):2843-8. PubMed ID: 3986811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences between neuroblastoma stages IV-S and IV.
    N Engl J Med; 1981 Dec; 305(23):1418-9. PubMed ID: 7300864
    [No Abstract]   [Full Text] [Related]  

  • 4. Models to predict outcome from childhood neuroblastoma: the role of serum ferritin and tumor histology.
    Silber JH; Evans AE; Fridman M
    Cancer Res; 1991 Mar; 51(5):1426-33. PubMed ID: 1997181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum ferritin as a prognostic indicator in neuroblastoma: biological effects of isoferritins.
    Hann HW; Stahlhut MW; Evans AE
    Prog Clin Biol Res; 1985; 175():331-45. PubMed ID: 3873075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of bone marrow evaluation in the staging of patients with otherwise localized, low-risk neuroblastoma.
    Russell HV; Golding LA; Suell MN; Nuchtern JG; Strother DR
    Pediatr Blood Cancer; 2005 Dec; 45(7):916-9. PubMed ID: 16078212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Biological indicators with a prognostic significance in neuroblastoma in children].
    Pein F; Hartmann O
    Bull Cancer; 1988; 75(1):83-6. PubMed ID: 3359058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum ferritin as a guide to therapy in neuroblastoma.
    Hann HW; Levy HM; Evans AE
    Cancer Res; 1980 May; 40(5):1411-3. PubMed ID: 6245792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroblastoma in the first year of life: clinical and biologic factors influencing outcome.
    Grosfeld JL; Rescorla FJ; West KW; Goldman J
    Semin Pediatr Surg; 1993 Feb; 2(1):37-46. PubMed ID: 8062021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum ferritin in stage IV neuroblastoma.
    Imashuku S; Yamanaka H; Morioka Y; Todo S
    Am J Pediatr Hematol Oncol; 1988; 10(1):39-41. PubMed ID: 3189716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroblastoma in adolescents: the Italian experience.
    Conte M; Parodi S; De Bernardi B; Milanaccio C; Mazzocco K; Angelini P; Viscardi E; Di Cataldo A; Luksch R; Haupt R
    Cancer; 2006 Mar; 106(6):1409-17. PubMed ID: 16475209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Leukoerythroblastosis as a manifestation of disseminated neuroblastoma in childhood].
    Couselo Sánchez JM; Méndez Rodríguez I; Fuster Siebert M; Castro Gago M; Monasterio Corral L; Iglesias Diz L
    Rev Esp Oncol; 1980; 27(4):571-8. PubMed ID: 7268159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Value of prognostic factors in the Austrian A-NB87 Neuroblastoma Study].
    Ladenstein R; Ambros PF; Urban C; Ambros IM; Fink FM; Zoubek A; Grienberger H; Schmitt K; Kerbl R; Horcher E; Amann G; Höfler G; Heinzl H; Gadner H; Mutz I
    Klin Padiatr; 1996; 208(4):210-20. PubMed ID: 8926686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroblastoma.
    Meir HM; Balawi I; Nayel H; Yousef MK; Badawood S; Al-Mobarak M
    Saudi Med J; 2001 Aug; 22(8):674-80. PubMed ID: 11573111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of natural antibody against human neuroblastoma among children with or without neuroblastoma.
    Fukuda M; Nozaki C; Ishiguro Y; Horibe K
    Med Pediatr Oncol; 2001 Jan; 36(1):147-8. PubMed ID: 11464870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neuroblastoma: biological markers, surgery, and clinical course].
    Martínez Ibáñez V; Abad P; Gallego S; Sánchez de Toledo J; Marqués A; Boix Ochoa J
    Cir Pediatr; 2000 Apr; 13(2):47-53. PubMed ID: 12602001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neuroblastoma IV-S. A multicenter study. Work Group of Pediatric Oncology. Spanish Society of Pediatric Surgery].
    Rollán Villamarín V; García Aroca J; Costa Borrás E; Cuadros García J; Jiménez Alvarez C; Martínez-Caro A; Martínez Ibáñez V; Mulet Ferragut F; Obiols Arderius P; Pérez La Fuente G
    Cir Pediatr; 1994 Oct; 7(4):167-70. PubMed ID: 7865360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of immunocytologic detection of bone marrow metastases in neuroblastoma.
    Moss TJ; Reynolds CP; Sather HN; Romansky SG; Hammond GD; Seeger RC
    N Engl J Med; 1991 Jan; 324(4):219-26. PubMed ID: 1985243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neuroblastoma at the Giannina Gaslini Institute. Analysis of 94 cases diagnosed 1972-1981].
    De Bernardi B; Garaventa A; Bartolini M; Rizzo A; Rosanda C; Bisogni C; Melodia A; Magnaguagno G; Ricci G; Lamedica G
    Pediatr Med Chir; 1983; 5(1-2):49-58. PubMed ID: 6634442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central nervous system metastases in neuroblastoma: radiologic, clinical, and biologic features in 23 patients.
    Matthay KK; Brisse H; Couanet D; Couturier J; Bénard J; Mosseri V; Edeline V; Lumbroso J; Valteau-Couanet D; Michon J
    Cancer; 2003 Jul; 98(1):155-65. PubMed ID: 12833468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.